Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | GPR3 | P46089 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.40 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.40 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.40 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.40 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.40 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.40 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
| ▸ | RXRB | P28702 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18565373 | 0.92 | RXRA (0.47) | KDM4EGPR3MAPTHSD17B10HPGD | |
| SCHEMBL13433119 | 0.92 | GPR3 (0.46) | KDM4EGPR3MAPTHSD17B10HPGD | |
| SCHEMBL17125533 | 0.92 | GPR3 (0.46) | KDM4EGPR3MAPTHSD17B10HPGD | |
| SCHEMBL19851432 | 0.91 | KDM4E (0.37) | KDM4EGPR3MAPTHSD17B10HPGD | |
| SCHEMBL22707768 | 0.90 | KDM4E (0.36) | KDM4EGPR3MAPTHSD17B10HPGD | |
| SCHEMBL18565410 | 0.89 | PSEN1 (0.34) | KDM4EMAPTHSD17B10HPGDMEN1 | |
| SCHEMBL18565445 | 0.87 | PTGES (0.33) | KDM4EGPR3MAPTHSD17B10MEN1 | |
| SCHEMBL24399844 | 0.87 | GPR3 (0.46) | KDM4EGPR3MAPTHSD17B10HPGD | |
| SCHEMBL19845134 | 0.86 | MEN1 (0.41) | KDM4EMAPTMEN1KMT2ALMNA | |
| SCHEMBL10085084 | 0.86 | KDM4E (0.45) | KDM4EMAPTMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10290815-B2 | Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-05-14 | — | — | US | disclosed |
| US-20170062733-A1 | COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-03-02 | — | — | US | disclosed |
| US-20170062733-A1 | COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-03-02 | — | — | US | disclosed |
| US-20100069647-A1 | Carbazole Derivative, Light-Emitting Element Material, Light-Emitting Element, and Light-Emitting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-03-18 | — | — | US | disclosed |
| US-20100069647-A1 | Carbazole Derivative, Light-Emitting Element Material, Light-Emitting Element, and Light-Emitting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-03-18 | — | — | US | disclosed |
| WO-2010005066-A1 | CARBAZOLE DERIVATIVE, LIGHT-EMITTING ELEMENT MATERIAL, LIGHT-EMITTING ELEMENT, AND LIGHT-EMITTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10290815-B2 | Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device | EED, BMI1, CD99 | KDM4E 225/4885GPR3 3915/4885MAPT 1057/4885 |
| US-20100069647-A1 | Carbazole Derivative, Light-Emitting Element Material, Light-Emitting Element, and Light-Emitting Device | CRY1, CHRM1, CYP1A1 | KDM4E 3714/4885GPR3 1794/4885MAPT 2426/4885 |
| US-20170062733-A1 | COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | EED, BMI1, CD99 | KDM4E 225/4885GPR3 3915/4885MAPT 1057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.